Min Dai1, Tao Jiang2, Cai-Dong Luo1, Wei Du1, Min Wang1, Qing-Yan Qiu1, Hu Wang1. 1. Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, 12 Changjia Alley, Fucheng District, Mianyang, 621000, Sichuan, China. 2. Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, 12 Changjia Alley, Fucheng District, Mianyang, 621000, Sichuan, China. afwmjcoa@yeah.net.
Abstract
BACKGROUND: In this study, we aimed to investigate the role of miR-26a and miR-26b in the management of AF. METHODS: Real-time PCR was carried out to determine plasma microRNA expression in AF patients pre- and post-radiofrequency ablation. The correlation between the expression of SELP and miR-26a/miR-26b was also studied using luciferase assays to establish a miR-26a/miR-26b/SELP signaling pathway. RESULTS: The relative expression of SELP reached its peak in pre-ablation AF ( +) patients, while ablation treatment reduced the expression of SELP in AF ( +) patients. Similarly, AF pigs showed dysregulation of miR-26a/b and SELP, thus verifying the involvement of miR-26a/b and SELP in AF. Meanwhile, the regulatory association between SELP and miR-26a/b was also investigated, and the results showed that the presence of pre-miR-26a/b increased the levels of miR-26a/b and inhibited the mRNA/protein expression of SELP. Finally, using bioinformatic tools and luciferase assays, SELP mRNA was confirmed as the target of miR-26a/b, which affected the effect of AF ablation treatment. CONCLUSIONS: RFA helped to restore circulating levels of miR-26, which were reduced in atrial fibrillation. Meanwhile, miR-26 is a potential cause for the elevated plasma levels of pro-thrombogenic SELP in that disease.
BACKGROUND: In this study, we aimed to investigate the role of miR-26a and miR-26b in the management of AF. METHODS: Real-time PCR was carried out to determine plasma microRNA expression in AF patients pre- and post-radiofrequency ablation. The correlation between the expression of SELP and miR-26a/miR-26b was also studied using luciferase assays to establish a miR-26a/miR-26b/SELP signaling pathway. RESULTS: The relative expression of SELP reached its peak in pre-ablation AF ( +) patients, while ablation treatment reduced the expression of SELP in AF ( +) patients. Similarly, AF pigs showed dysregulation of miR-26a/b and SELP, thus verifying the involvement of miR-26a/b and SELP in AF. Meanwhile, the regulatory association between SELP and miR-26a/b was also investigated, and the results showed that the presence of pre-miR-26a/b increased the levels of miR-26a/b and inhibited the mRNA/protein expression of SELP. Finally, using bioinformatic tools and luciferase assays, SELP mRNA was confirmed as the target of miR-26a/b, which affected the effect of AF ablation treatment. CONCLUSIONS: RFA helped to restore circulating levels of miR-26, which were reduced in atrial fibrillation. Meanwhile, miR-26 is a potential cause for the elevated plasma levels of pro-thrombogenic SELP in that disease.
Authors: Sung-Il Im; Aleksandr Voskoboinik; Adam Lee; Satoshi Higuchi; Joshua D Moss; Henry Hsia; Zian H Tseng; Randall Lee; Gregory M Marcus; Vasanth Vedantham; Melvin Scheinman; Byron Lee; Kyoung-Min Park; Edward P Gerstenfeld Journal: J Cardiovasc Electrophysiol Date: 2021-06-06
Authors: Peter Bugert; Marion Vosberg; Mathias Entelmann; Jürgen Jahn; Hugo A Katus; Harald Klüter Journal: Clin Chem Lab Med Date: 2004 Impact factor: 3.694
Authors: Thomas Rostock; Daniel Steven; Boris Lutomsky; Helge Servatius; Imke Drewitz; Hanno Klemm; Kai Müllerleile; Rodolfo Ventura; Thomas Meinertz; Stephan Willems Journal: J Am Coll Cardiol Date: 2008-06-03 Impact factor: 24.094
Authors: D A Tregouet; S Barbaux; O Poirier; S Blankenberg; C Bickel; S Escolano; H J Rupprecht; J Meyer; F Cambien; L Tiret Journal: Ann Hum Genet Date: 2003-11 Impact factor: 1.670